Incyte (INCY) EBT Margin (2009 - 2026)
Incyte (INCY) posted EBT Margin of -44.24% for Q3 2026, down 79.54 percentage points from 35.31% a year earlier and down 89.13 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EBT Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBT Margin at Incyte was 13.25%, down 19.75 percentage points year-over-year; for FY2025, it came in at 32.37%, up 24.91 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of +41.08 percentage points (FY2020 to FY2025).
- In prior years, Incyte's EBT Margin was 7.47% in FY2024 (-15.11 pp), 22.57% in FY2023 (+6.99 pp), 15.59% in FY2022 (-3.52 pp) and 19.10% in FY2021 (+27.81 pp).
- The Q3 2026 figure stands as the lowest quarterly EBT Margin since Q1 2020.
- On a year-over-year basis, EBT Margin increased in three of the last eight quarters, with an average year-over-year change of +2.95 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q2 2025, with a gain of 83.25 percentage points; the weakest was Q3 2026, with a drop of 79.54 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was 44.89% (Q2 2026), 27.00% (Q1 2026) and 25.88% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -44.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -44.24% |
| Jun 30, 2026 | 44.89% |
| Mar 31, 2026 | 27.00% |
| Dec 31, 2025 | 25.88% |
| Sep 30, 2025 | 35.31% |
| Jun 30, 2025 | 45.91% |
| Mar 31, 2025 | 22.24% |
| Dec 31, 2024 | 26.62% |
| Sep 30, 2024 | 13.76% |
| Jun 30, 2024 | -37.34% |
| Mar 31, 2024 | 26.81% |
| Dec 31, 2023 | 26.74% |
| Sep 30, 2023 | 25.44% |
| Jun 30, 2023 | 29.08% |
| Mar 31, 2023 | 6.41% |
| Dec 31, 2022 | 8.70% |
| Sep 30, 2022 | 18.05% |
| Jun 30, 2022 | 25.17% |
| Mar 31, 2022 | 9.62% |
| Dec 31, 2021 | 13.91% |
API Access
Incyte EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();